About Flexion Therapeutics
Flexion Therapeutics is a company based in Woburn (United States) founded in 2007 was acquired by Pacira in October 2021.. Flexion Therapeutics has raised $62 million across 4 funding rounds from investors including Pfizer, Pacira and 5AM Ventures. The company has 692 employees as of December 31, 2022. Flexion Therapeutics operates in a competitive market with competitors including Formation Bio, Eliem Therapeutics, Zogenix, Heron Therapeutics and Ethypharm, among others.
- Headquarter Woburn, United States
- Employees 692 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$85.55 M17as on Dec 31, 2020
-
Net Profit
$-113.71 M24as on Dec 31, 2020
-
EBITDA
$-93.02 M32as on Dec 31, 2020
-
Total Equity Funding
$62 M (USD)
in 4 rounds
-
Latest Funding Round
$175 M (USD), Post-IPO
May 01, 2017
-
Investors
Pfizer
& 6 more
-
Employee Count
692
as on Dec 31, 2022
-
Acquired by
Pacira
(Oct 11, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Leadership Team
105 people
Account Team
28 people
Software Development Team
20 people
Sales and Marketing
18 people
Senior Team
14 people
Product Management Team
13 people
Finance and Accounting
11 people
Operations Team
11 people
Unlock access to complete
Funding Insights of Flexion Therapeutics
Flexion Therapeutics has successfully raised a total of $62M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $175 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $175.0M
-
First Round
First Round
(16 Oct 2009)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2017 | Amount | Post-IPO - Flexion Therapeutics | Valuation |
investors |
|
| Apr, 2017 | Amount | Post-IPO - Flexion Therapeutics | Valuation |
investors |
|
| Dec, 2012 | Amount | Series B - Flexion Therapeutics | Valuation | Novo Holdings |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Flexion Therapeutics
Flexion Therapeutics has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, Pacira and 5AM Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed incubator focused on the healthcare startups
|
Founded Year | Domain | Location | |
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Founded Year | Domain | Location | |
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Flexion Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Flexion Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Flexion Therapeutics Comparisons
Competitors of Flexion Therapeutics
Flexion Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Formation Bio, Eliem Therapeutics, Zogenix, Heron Therapeutics and Ethypharm, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-powered drug discovery platform for various diseases
|
|
| domain | founded_year | HQ Location |
Develops antibody-based treatments for autoimmune and inflammatory disorders.
|
|
| domain | founded_year | HQ Location |
Drug delivery systems for CNS disorders and pain are developed.
|
|
| domain | founded_year | HQ Location |
Reformulated injectables for chemotherapy side effects and pain are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for pain and addiction treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Flexion Therapeutics
Frequently Asked Questions about Flexion Therapeutics
When was Flexion Therapeutics founded?
Flexion Therapeutics was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Where is Flexion Therapeutics located?
Flexion Therapeutics is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Is Flexion Therapeutics a funded company?
Flexion Therapeutics is a funded company, having raised a total of $62M across 4 funding rounds to date. The company's 1st funding round was a Series B of $20M, raised on Oct 16, 2009.
How many employees does Flexion Therapeutics have?
As of Dec 31, 2022, the latest employee count at Flexion Therapeutics is 692.
What is the annual revenue of Flexion Therapeutics?
Annual revenue of Flexion Therapeutics is $85.55M as on Dec 31, 2020.
What does Flexion Therapeutics do?
Developer of therapies for the treatment of musculoskeletal disorders. The company is currently advancing a portfolio of injectable drug candidates that have the potential to provide better and more persistent analgesia compared with existing therapies. Their lead program, FX006, is an intra-articular sustained-release steroid injectable for patients with moderate to severe osteoarthritis (OA) pain. They also have two additional product candidates FX007, a locally administered TrkA receptor antagonist for post-operative pain, and FX005, an intra-articular, sustained-release p38 MAP kinase inhibitor for end-stage OA patients.
Who are the top competitors of Flexion Therapeutics?
Flexion Therapeutics's top competitors include Formation Bio, Cara Therapeutics and PainReform.
Who are Flexion Therapeutics's investors?
Flexion Therapeutics has 7 investors. Key investors include Pfizer, Pacira, 5AM Ventures, Versant Ventures, and Novo Holdings.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.